Peter Powchik - Regeneron Pharmaceuticals Senior Vice President - Clinical Development

REGN -- USA Stock  

USD 286.15  9.72  3.29%

  President
Dr. Peter Powchik, M.D., is Senior Vice President Clinical Development of the Company. Dr. Powchik was employed at several pharmaceutical companies, serving as Senior Vice President and Chief Medical Officer of Chugai Pharma USA, a position he held from May 2005 until October 2006. From April 2001 until May 2005, he held various senior clinical development positions at Novartis Pharmaceuticals Corporationrationration, most recently as Vice President, US Clinical Development and Medical Affairs. Dr. Powchik held various clinical development positions with Sepracor Inc. and Pfizer Inc. from October 1996 to April 2001. Dr. Powchik received his M.D. from New York University School of Medicine.
Age: 59  President Since 2006      
914-847-7000  http://www.regeneron.com

Peter Powchik Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 11.57 % which means that it generated profit of $11.57 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 24.43 % meaning that it created $24.43 on every $100 dollars invested by stockholders.
The company currently holds 711.3M in liabilities with Debt to Equity (D/E) ratio of 7.2 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Regeneron Pharmaceuticals has Current Ratio of 3.8 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Showing few of many executives

PRESIDENT Since

Paul SilvaVertex Pharmaceuticals Incorpor
2019
Sripada ChandrasekharDr Reddys Laboratories Ltd
2013
Thomas FarringtonPerrigo Company plc
2015
Stefan WeiskopfZoetis
2013
Ganadhish KamatDr Reddys Laboratories Ltd
2016
Ronald JanishPerrigo Company plc
2015
Michael StewartPerrigo Company plc
2004
Jeffrey NeedhamPerrigo Company plc
2009
Umang VohraDr Reddys Laboratories Ltd
2013
Alok SonigDr Reddys Laboratories Ltd
2015
John HendricksonPerrigo Company plc
2016
Reshma KewalramaniVertex Pharmaceuticals Incorpor
2018
Joyce LeeZoetis
2012
Thomas GraneyVertex Pharmaceuticals Incorpor
2017
Paul WeningerPerrigo Company plc
2015
James DillardPerrigo Company plc
2019
Catherine KnuppZoetis
2012
Louis YuPerrigo Company plc
2013
James MichaudPerrigo Company plc
2016
Grainne QuinnPerrigo Company plc
2016
Andrew FentonZoetis
2018

Entity Summary

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for treating various medical conditions worldwide. Regeneron Pharmaceuticals, Inc. was founded in 1988 and is headquartered in Tarrytown, New York. Regeneron Pharmaceuticals operates under Biotechnology classification in USA and is traded on BATS Exchange. It employs 7549 people.Regeneron Pharmaceuticals (REGN) is traded on BATS Exchange in USA and employs 7,549 people.

Regeneron Pharmaceuticals Leadership Team

Charles Baker, Independent Director
Joseph Goldstein, Independent Director
Anthony Coles, Independent Director
George Sing, Independent Director
Peter Powchik, Senior Vice President - Clinical Development
Jay Markowitz, Senior Vice President - Portfolio Management
Robert Terifay, Sr. VP of Commercial
Robert Landry, CFO and Sr. VP of Fin.
Michael Brown, Independent Director
Christine Poon, Independent Director
Neil Stahl, Executive VP of RandD
Marion McCourt, Senior Vice President and Head of Commercial
George Yancopoulos, Chief Scientific Officer and President - Regeneron Laboratories, Director
Huda Zoghbi, Director
Bonnie Bassler, Director
Joseph LaRosa, Senior Vice President General Counsel, Secretary
Daniel Plew, Senior Vice President General Manager - Industrial Operations and Product Supply
Leonard Schleifer, President CEO, Director
Alfred Gilman, Independent Director
Roy Vagelos, Chairman of the Board
Michael Aberman, Vice President - Strategy
Manisha Narasimhan, IR Contact
Douglas McCorkle, Vice President Controller, Assistant Treasurer
Marc TessierLavigne, Independent Director
Christopher Fenimore, Vice President Controller
Arthur Ryan, Independent Director

Stock Performance Indicators

Did you try this?

Run Competition Analyzer Now

   

Competition Analyzer

Analyze and compare many basic indicators for a group of related or unrelated entities
All  Next Launch Module

Currently Active Assets on Macroaxis

GOOG   
Purchased one share of
few hours ago
Traded for 1221.15
UGAZ   
Purchased over 100 shares of
few hours ago
Traded for 19.55
TWTR   
Purchased over 40 shares of
few hours ago
Traded for 43.23
JD   
Purchased over 60 shares of
few hours ago
Traded for 30.83
MDT   
Purchased few shares of
few hours ago
Traded for 111.18
Additionally take a look at Your Equity Center. Please also try Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Search macroaxis.com